Please complete the following questions.  Those marked with an asterick(*) are required.

Question Title

* Which antiemetic regimen is recommended by all major international guidelines for acute emesis in a patient receiving carboplatin (AUC 6)?

Question Title

* Which of the following is not true regarding NK1 RAs?

Question Title

* Based on the CINV risk prediction model to assess individualized risk for grade ≥ 2 CINV (Dranitsaris Ann Oncol 2017), which variable is not predictive of CINV?

Question Title

* How often do you now PLAN TO DO the following:



Most of
the time


Apply current guidelines to select antiemetic prophylaxis for patients receiving HEC, MEC regimens
Consider fixed-combination strategies to simplify antiemetic treatment regimens
Use an NK1 receptor antagonist of fixed-combination regimen in patients receiving carboplatin-based chemotherapy
Thank you for your time and participation.
Please click the SUBMIT button below to complete this activity.